Eisenmenger syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Eisenmenger syndrome | |
|---|---|
| File:Eisenmenger Syndrome.png | |
| Synonyms | |
| Pronounce | |
| Specialty | Cardiology |
| Symptoms | Cyanosis, dyspnea, fatigue, syncope, chest pain |
| Complications | Heart failure, stroke, arrhythmias |
| Onset | Usually in adulthood |
| Duration | Chronic |
| Types | |
| Causes | Congenital heart defect with left-to-right shunt |
| Risks | |
| Diagnosis | Echocardiography, cardiac catheterization |
| Differential diagnosis | |
| Prevention | Early repair of congenital heart defects |
| Treatment | Oxygen therapy, phlebotomy, pulmonary vasodilators |
| Medication | Bosentan, sildenafil, epoprostenol |
| Prognosis | Variable, depends on severity and management |
| Frequency | Rare |
| Deaths | |
A complex heart condition resulting from long-standing heart defects
Eisenmenger syndrome is a medical condition that arises as a complication of certain congenital heart defects. It is characterized by the reversal of a left-to-right shunt to a right-to-left shunt due to the development of pulmonary hypertension. This condition leads to cyanosis, or a bluish discoloration of the skin, due to decreased oxygenation of the blood.
Pathophysiology[edit]
Eisenmenger syndrome develops in patients with congenital heart defects that initially cause a left-to-right shunt, such as a ventricular septal defect, atrial septal defect, or patent ductus arteriosus. Over time, the increased blood flow to the lungs causes damage to the pulmonary vasculature, leading to pulmonary hypertension. As the pressure in the pulmonary arteries rises, it eventually exceeds the systemic blood pressure, causing the shunt to reverse direction (right-to-left), resulting in deoxygenated blood entering the systemic circulation.
Clinical Features[edit]
Patients with Eisenmenger syndrome typically present with symptoms such as cyanosis, dyspnea (shortness of breath), and fatigue. The condition may also lead to complications such as hemoptysis (coughing up blood), arrhythmias, and heart failure. One of the characteristic physical findings in Eisenmenger syndrome is digital clubbing, which is the enlargement of the fingertips and toes.

Diagnosis[edit]
The diagnosis of Eisenmenger syndrome is based on clinical evaluation, imaging studies, and cardiac catheterization. Echocardiography is often used to assess the heart's structure and function, while chest X-ray and CT scan can provide additional information about the pulmonary vasculature. Cardiac catheterization is the definitive test to measure pulmonary artery pressures and confirm the presence of a right-to-left shunt.
Management[edit]
Management of Eisenmenger syndrome focuses on controlling symptoms and preventing complications. Patients are advised to avoid activities that can exacerbate symptoms, such as strenuous exercise and high altitudes. Medical therapy may include oxygen therapy, diuretics, and anticoagulants. In some cases, pulmonary vasodilators such as bosentan or sildenafil may be used to reduce pulmonary artery pressure. Heart-lung transplantation is considered in severe cases.
Prognosis[edit]
The prognosis of Eisenmenger syndrome varies depending on the severity of the condition and the presence of complications. With appropriate management, many patients can live into adulthood, although the condition is associated with a reduced life expectancy compared to the general population.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian